Immune Bone Crosstalk
Immune Bone Crosstalk - Related Videos
14:43
Differentiating Functional Roles of Gene Expression from Immune and Non-immune Cells in Mouse Colitis by Bone Marrow Transplantation
0 Views •
Cited by 2 •
2012
Bone marrow transplantation provides a way to change the genotype of the bone marrow derived cells. If the gene of interest is expressed in both bone marrow derived cells and non-bone marrow derived cells, bone marrow transplantation can change the bone marrow derived cells to a different genotype without changing the non-bone marrow derived cell genotype.
08:49
Models of Bone Metastasis
0 Views •
Cited by 115 •
2012
Animal models are frequently utilized to study cancer metastasis to bone. In this protocol we will describe two common methods of tumor inoculation for bone metastasis studies and briefly describe some of the analyses utilized to monitor and quantify these models.
01:38
What is the Immune System?
0 Views •
2019
Overview The immune system comprises diverse biological structures and processes that protect the body from disease. These processes can be classified into innate and adaptive immunity. To work effectively, the immune system needs to detect pathogens by distinguishing the body’s own structures from foreign elements. If this determination fails, autoimmune diseases occur in which the immune system reacts against the body’s own tissue. The Innate Immune System Acts Fast and Non-specifically
06:28
Isolating Immune Cells from Mouse Brain and Skull
0 Views •
Cited by 1 •
2024
To investigate the immune response to brain disorders, one common approach is to analyze changes in immune cells. Here, two simple and effective protocols are provided for isolating immune cells from murine brain tissue and skull bone marrow.
07:36
Contact-Free Co-Culture Model for the Study of Innate Immune Cell Activation During Respiratory Virus Infection
0 Views •
Cited by 1 •
2021
This protocol details an investigation of the early interactions between virally infected nasal epithelial cells and innate cell activation. Individual subsets of immune cells can be distinguished based on their activation in response to viral infections. They can then be further investigated to determine their effects on early antiviral responses.
FAQs
RANKL provides a key link between immune signaling and skeletal remodeling. Immune-derived RANKL regulates osteoclast differentiation and activity, so changes in immune signaling can alter the cells responsible for bone resorption. This connection explains why inflammatory states may affect skeletal remodeling rather than remaining confined to immune tissues, making RANKL relevant when investigating coupled changes in inflammation and bone integrity.
Osteoblasts and bone marrow stromal cells do more than support skeletal tissue. Through direct cell contact and soluble mediators, they influence immune-cell development and function. In parallel, bone-resorbing cells participate in the same signaling network. These relationships place bone-forming, marrow-supporting, and bone-resorbing populations within the regulation of immune balance and hematopoiesis.
A one-way model would miss how immune signals affect bone and how skeletal cells feed signals back into immune processes. This reciprocal organization helps explain how local changes can propagate across inflammation, remodeling, and blood-cell formation. It also provides a framework for studying whether disrupted communication contributes to disease instead of treating bone and immunity as separate systems.
Immune bone crosstalk becomes medically important when its regulatory network is disturbed. The overview identifies inflammatory arthritis, osteoporosis, infection-related bone loss, and tumor growth in bone as settings in which dysregulation can promote pathology. These examples show that similar communication principles may produce distinct outcomes depending on whether inflammation, infection, skeletal fragility, or malignancy predominates.
Understanding this network supports therapies aimed at both immune pathways and skeletal remodeling. This combined focus matters because altering inflammation alone may not address changes in osteoclast activity or bone integrity, while targeting remodeling alone may overlook immune drivers. The framework therefore encourages coordinated investigation of immune and skeletal effects when developing medical strategies.
Bone marrow provides a context in which skeletal and immune processes intersect. Osteoblasts, stromal cells, and bone-resorbing cells influence immune-cell development and function, linking remodeling with hematopoiesis. Considering both processes can clarify how changes in the marrow environment affect immune balance and why skeletal disease research may also inform understanding of immune-system biology.